(Q33256000)

24 July 2017

1 reference

title

Laryngeal preservation in head and neck cancer: multidisciplinary approach (English)

1 reference

24 July 2017

0 references

1 reference

1 reference

head and neck carcinoma

1 reference

Jean Louis Lefebvre

1

1 reference

24 July 2017

1 September 2006

1 reference

Lancet Oncology Commission

24 July 2017

1 reference

24 July 2017

7

1 reference

24 July 2017

9

1 reference

24 July 2017

747-755

1 reference

Conservation laryngeal surgery for malignant tumors of the larynx and pyriform sinus

24 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Treatment of laryngeal cancer: the permanent challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Supraglottic hemilaryngopharyngectomy plus radiation for the treatment of early lateral margin and pyriform sinus carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Supracricoid hemilaryngopharyngectomy in patients with invasive squamous cell carcinoma of the pyriform sinus. Part I: Technique, complications, and long-term functional outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Supracricoid laryngectomy with cricohyoidopexy: a partial laryngeal procedure for selected supraglottic and transglottic carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Supracricoid laryngectomy with cricohyoidoepiglottopexy: a partial laryngeal procedure for glottic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Near-total laryngectomy for treatment of advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Supracricoid partial laryngectomies after failure of radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Laryngeal preservation with supracricoid partial laryngectomy results in improved quality of life when compared with total laryngectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Transoral laser surgery of supraglottic cancer: follow-up of 141 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

CO(2) laser surgery in the treatment of glottic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Complications in transoral CO2 laser surgery for carcinoma of the larynx and hypopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Organ preservation by transoral laser microsurgery in piriform sinus carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Transoral carbon-dioxide laser resection of hypopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

T3-4 squamous cell carcinoma of the larynx treated with radiation therapy alone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Cancer of the larynx--treatment results after primary radiotherapy with salvage surgery in a series of 1005 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Hyperfractionated Radiation Therapy for Hypopharyngeal Carcinoma Compared with Conventional Radiation Therapy: Local Control, Laryngeal Preservation and Overall Survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in Stage III and IV squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Randomized trial of induction chemotherapy in larynx carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Larynx preservation after initial non-cisplatin containing combination chemotherapy plus radiotherapy, as opposed to surgical intervention with or without radiotherapy in previously untreated advanced head and neck cancer: final analysis after 12 ye

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced laryngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Laryngeal preservation by treatment with induction chemotherapy and radiotherapy protocol for stage III & IV carcinoma larynx--results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Laryngeal preservation in cases of advanced laryngeal cancer treated with platinum based induction chemotherapy befire local treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced pyriform sinus carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Larynx Preservation Using Induction Chemotherapy plus Radiation Therapy as an Alternative to Laryngectomy in Advanced Head and Neck Cancer A Long-Term Follow-up Report

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Laryngeal preservation for advanced laryngeal and hypopharyngeal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Induction chemotherapy with paclitaxel and cisplatin and CT-based 3D radiotherapy in patients with advanced laryngeal and hypopharyngeal carcinomas--a possibility for organ preservation.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. The Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Predictive markers for response to chemotherapy, organ preservation, and survival in patients with advanced laryngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Chemotherapy alone with curative intent in patients with invasive squamous cell carcinoma of the pharyngolarynx classified as T1-T4N0M0 complete clinical responders

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Hyperfractionated radiotherapy and concomitant cisplatin for locally advanced laryngeal and hypopharyngeal carcinomas: final results of a single institutional program

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Voice and swallowing in patients enrolled in a larynx preservation trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Auditory effects after organ preservation protocol for laryngeal/hypopharyngeal carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

How much does it cost to preserve a larynx? An economic study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Cost comparison of surgery vs organ preservation for laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania Phase II Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resecta

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970860-9

7 January 2021

10.1016/S1470-2045(06)70860-9

Identifiers

DOI

1 reference

24 July 2017

1 reference

PubMed ID

16945770